Growth Metrics

Thermo Fisher Scientific (TMO) Net Income towards Common Stockholders (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Net Income towards Common Stockholders readings, the most recent being $1.7 billion for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 9.95% to $1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $6.9 billion, a 6.12% increase, with the full-year FY2025 number at $6.8 billion, up 6.61% from a year prior.
  • Net Income towards Common Stockholders hit $1.7 billion in Q1 2026 for Thermo Fisher Scientific, down from $2.0 billion in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $2.2 billion in Q2 2022 to a low of $1.3 billion in Q2 2023.
  • Median Net Income towards Common Stockholders over the past 5 years was $1.6 billion (2023), compared with a mean of $1.6 billion.
  • The widest YoY moves for Net Income towards Common Stockholders: up 14.72% in 2023, down 41.81% in 2023.
  • Thermo Fisher Scientific's Net Income towards Common Stockholders stood at $1.6 billion in 2022, then rose by 3.43% to $1.6 billion in 2023, then grew by 12.27% to $1.8 billion in 2024, then grew by 8.91% to $2.0 billion in 2025, then dropped by 16.86% to $1.7 billion in 2026.
  • The last three reported values for Net Income towards Common Stockholders were $1.7 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.6 billion (Q3 2025) per Business Quant data.